Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
954.4 INR | +0.78% | -3.38% | +47.00% |
23/05 | Strides Pharma Science Turns to Consolidated Net Profit in Fiscal Q4; Shares Down 3% | MT |
22/05 | Transcript : Strides Pharma Science Limited, Q4 2024 Earnings Call, May 22, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+47.00% | 1.04B | |
+20.78% | 43.29B | |
+27.64% | 22.38B | |
+19.25% | 15.51B | |
+18.68% | 14.52B | |
+54.64% | 12.93B | |
-0.05% | 6.79B | |
-11.39% | 6.56B | |
+18.33% | 5.87B | |
-8.87% | 5.73B |
- Stock Market
- Equities
- STAR Stock
- News Strides Pharma Science Limited
- Strides Pharma Science Arm Gets US FDA Nod for Sevelamer Carbonate for Oral Suspension